This bill addresses the issue of opioid use disorder (OUD) and the utilization of buprenorphine, a medication used to treat OUD. The legislative findings highlight the role of state legislatures in mandating or encouraging state agency action to remove barriers to the use of buprenorphine, appropriating funds for related services, and holding oversight hearings. It emphasizes the importance of states collecting data on OUD prevalence and treatment rates, as well as reviewing structural barriers that may hinder efforts to combat opioid addiction. The bill also notes the need for comprehensive care for individuals with OUD, including treatment for co-occurring mental illnesses and access to social supports.

The bill proposes an amendment to Section 21-28.2-2 of the General Laws in Chapter 21-28.2 entitled "Drug Abuse Control." The amendment includes new legal language that would authorize the department of health to adopt rules and regulations that lead to the more liberal utilization of buprenorphine for the care and treatment of patients with OUD. The insertion specifies that the department shall make rules and regulations, including those that promote the liberal use of buprenorphine. The bill is set to take effect upon passage, indicating an immediate change in policy once enacted.

Statutes affected:
119: 21-28.2-2